PUBLISHER: DataM Intelligence | PRODUCT CODE: 1002234
PUBLISHER: DataM Intelligence | PRODUCT CODE: 1002234
Global Pet Cancer Therapeutics Market, Size, Share, Opportunities and Forecast, 2020-2027
Contact us about how to customize the report with add-on data.
Global Pet Cancer Therapeutics Market Size By Medicine Type (Chemotherapy Drugs, Vaccines, Immunotherapy, and others), By Animal(Dogs, Cats, Horses, and others), By Cancer Type (Lymphoma, Mast Cell Cancer, Melanoma, Mammary, and Squamous Cell Cancer), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Share, Size, Outlook, and Opportunity Analysis, 2020-2027
Market Overview
The Pet Cancer Therapeutics Market is expected to grow at a CAGR of 10.3% during the forecasting period (2020-2027).
Why purchase the report?
Visualize the composition of the Pet Cancer Therapeutics Market products across each indication, regarding type and application highlighting the critical commercial assets and players.
Identify business opportunities in Pet Cancer Therapeutics Market products market by analyzing trends and co-development deals.
Excel data sheet with thousands of data points of the Pet Cancer Therapeutics Market products levels 4/5 segmentation.
PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
Product mapping in excel for the essential Pet Cancer Therapeutics Market products of all major market players.
Who can benefit from this report?
Raw Material Suppliers/ Buyers
Product Suppliers/ Buyers
Industry Investors/Investment Bankers
Education & Research Institutes
Research Professionals
Emerging Companies
Manufacturers
Table of Contents
Table of Contents
1. Global Pet Cancer Therapeutics Market Methodology and Scope
- 1.1. Research Methodology
- 1.2. Research Objective and Scope of the Report
2. Global Pet Cancer Therapeutics Market - Market Definition and Overview
3. Global Pet Cancer Therapeutics Market - Executive Summary
- 3.1. Market Snippet by Medication Type
- 3.2. Market Snippet by Animal
- 3.3. Market Snippet by Cancer Type
- 3.4. Market Snippet by Region
4. Global Pet Cancer Therapeutics Market - Market Dynamics
- 4.1. Market Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. High Prevalence of Cancer in Pets
- 4.1.1.2. Launch of novel drugs
- 4.1.2. Restraints
- 4.1.2.1. High Cost of pet cancer drugs
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis
- 4.1.1. Drivers
5. Global Pet Cancer Therapeutics Market - Industry Analysis
- 5.1. Porter's Five Forces Analysis
- 5.2. Regulatory Analysis
- 5.3. Patent Analysis
6. Global Pet Cancer Therapeutics Market - Epidemiology Analysis
7. Global Pet Cancer Therapeutics Market - Pipeline Analysis
8. Global Pet Cancer Therapeutics Market - By Medication Type
- 8.1.1. Introduction
- 8.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medication Type
- 8.1.3. Market Attractiveness Index, By Medication Type
- 8.2. Chemotherapy Drugs
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
- 8.3. Targeted Drugs
- 8.4. Immunotherapy
- 8.5. Vaccines
- 8.6. Others
9. Global Pet Cancer Therapeutics Market - By Animal
- 9.1.1. Introduction
- 9.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal
- 9.1.3. Market Attractiveness Index, By Animal
- 9.2. Dogs
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
- 9.3. Cats
- 9.4. Horses
- 9.5. Others
10. Global Pet Cancer Therapeutics Market - By Cancer Type
- 10.1.1. Introduction
- 10.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type
- 10.1.3. Market Attractiveness Index, By Cancer Type
- 10.2. Lymphoma
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
- 10.3. Melanoma
- 10.4. Squamous Cell Cancers
- 10.5. Others
11. Global Pet Cancer Therapeutics Market - By Region
- 11.1. Introduction
- 11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
- 11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type
- 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medication Type
- 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal
- 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 11.2.6.1. The U.S.
- 11.2.6.2. Canada
- 11.2.6.3. Mexico
- 11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type
- 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medication Type
- 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal
- 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 11.3.6.1. Germany
- 11.3.6.2. The U.K.
- 11.3.6.3. France
- 11.3.6.4. Italy
- 11.3.6.5. Spain
- 11.3.6.6. Rest of Europe
- 11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type
- 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medication Type
- 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal
- 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 11.4.6.1. Brazil
- 11.4.6.2. Argentina
- 11.4.6.3. Rest of South America
- 11.5. Asia Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type
- 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medication Type
- 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal
- 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 11.5.6.1. China
- 11.5.6.2. India
- 11.5.6.3. Japan
- 11.5.6.4. Australia
- 11.5.6.5. Rest of Asia Pacific
- 11.6. Middle East & Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type
- 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medication Type
- 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal
12. Global Pet Cancer Therapeutics Market - Competitive Landscape
- 12.1. Competitive Scenario
- 12.2. Competitor Pet Cancer Therapeutics Strategy Analysis
- 12.3. Comparative Product Portfolio Analysis
- 12.4. Market Positioning/Share Analysis
- 12.5. Mergers and Acquisitions Analysis
13. Global Pet Cancer Therapeutics Market - Company Profiles
- 13.1. Zoetis
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Key Highlights
- 13.1.4. Financial Overview
- 13.2. Merial (Boehringer Ingelheim GmbH)
- 13.3. Aratana Therapeutics
- 13.4. Morphogenesis Inc
- 13.5. Vetivax
- 13.6. VetDC
- 13.7. Regeneus
- 13.8. Karyopharms Verdinexor
- 13.9. AdvaVet Inc. (Oasmia Pharmaceuticals AB)
- 13.10. CanFel Therapeutics
14. Global Pet Cancer Therapeutics Market - Premium Insights
15. Global Pet Cancer Therapeutics Market - DataM
- 15.1. Appendix
- 15.2. About Us and Services
- 15.3. Contact Us
